myocyte enhancer factor
Myocyte Enhancer Factor 2A (MEF2A) Defines Oxytocin-Induced Morphological Effects and Regulates Mitochondrial Function in Neurons
... common factor between ASD, its underlying disturbed cellular functions and the oxytocinergic system, is the transcription factor myocyte enhancer factor (MEF) ...
26
Association of novel polymorphisms in the bovine myocyte enhancer factor 2D (MEF2D) gene with carcass traits of Polish Holstein Friesian cattle
... ABSTRACT: In the present study the polymorphism of the myocyte enhancer factor 2D (MEF2D) gene was analyzed as a genetic marker candidate for carcass traits in Polish Holstein-Friesian cattle. Four ...
8
Myocyte enhancer factor 2C function in skeletal muscle is required for normal growth and glucose metabolism in mice
... Myocyte enhancer factor 2 (MEF2) proteins function as key transcriptional regulators of skeletal muscle devel- opment, sarcomeric gene expression, fiber type control, and glucose uptake metabolism ...
10
Adult Myogenesis in Drosophila melanogaster Can Proceed Independently of Myocyte Enhancer Factor-2
... Myocyte enhancer factor-2 (MEF2) is a transcription factor that is necessary for embryonic muscle develop- ment in Drosophila and vertebrates; however, whether this factor is required ...
14
Myocyte enhancer factor 2D provides a cross talk between chronic inflammation and lung cancer
... Results: Bioinformatics analyses of the 16 enrolled GSE datasets from Gene Expression Omnibus online database showed myocyte enhancer factor 2D (MEF2D) level significantly increased in COPD patients ...
10
Transcription factor myocyte enhancer factor 2D regulates interleukin-10 production in microglia to protect neuronal cells from inflammation-induced death
... necrosis factor alpha (TNF-α) and interleukin-1 beta (IL-1β) [6,7] but also by producing hyperoxides and peroxi- dases including reactive oxygen species (ROS) and NADPH oxidase ...
10
Contribution of Myocyte Enhancer Factor 2 Family Transcription Factors to BZLF1 Expression in Epstein-Barr Virus Reactivation from Latency
... growth factor independent 1B (GFI1B), NFIL3, and MAFB, en- code b-Zip-type transcription ...b-Zip factor binding motif ZII is mutated; pZpmZIII-luc (mZIII), bearing a point mutation in the binding site of ...
15
Myocyte enhancer factor (MEF) 2 plays essential roles in T cell transformation associated with HTLV 1 infection by stabilizing complex between Tax and CREB
... sponse factor) domain whereas the highly variable C- termini contain transcription activation domains (TADs), which recruit coactivators, histone modification enzymes and factors associated with nucleosome ...
24
High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children’s Oncology Group
... Increasing evidence also suggests an important role of MEF2C in the normal hematopoietic system, particularly for the production of immature and mature lymphoid cells and as a modulator of the cell fate decision between ...
10
Inhibition of myocyte-specific enhancer factor 2A improved diabetic cardiac fibrosis partially by regulating endothelial-to- mesenchymal transition
... Myocyte enhancer factor 2A (MEF2A) belongs to a family of four closely related transcription factors (MEF2A, -B, -C, and -D) that are conserved from yeast to humans ...transcription factor in ...
14
Histone deacetylase degradation andMEF2 activation promote the formation of slow twitch myofibers
... the myocyte enhancer factor 2 (MEF2) transcription factor, fail to accumulate in the soleus, a slow muscle, compared with fast muscles ...
10
Two new splice variants in porcine PPARGC1A
... respiratory factor 1; PPARγ, peroxisome proliferator- activated receptor γ; MEF2C, myocyte enhancer factor 2C; SR, serine-arginine-rich domain; RRM, RNA recognition motif ...
7
Original Article Knockdown of miR-125-3p protects against oxidative stress in PC-12 cells by targeting MEF2
... Abstract: Aim: Spinal cord injury (SCI) is a devastating and common neurological disorder which causes local oxida- tive damage. The study aimed to investigate the underlying role of miR-125-3p mediated by expression of ...
9
Let-7a Is an Antihypertrophic Regulator in the Heart via Targeting Calmodulin
... (myocyte enhancer factor 2); the current study showed that let-7a inhibited AngII-induced cardiac hypertrophy by targeting CaM gene, indicating that a single miRNA can regulate more hypertrophic ...
10
Phasing of muscle gene expression with fasting induced recovery growth in Atlantic salmon
... growth factor I (IGF- I), myogenin (MYOG), myoblast determination factor 1 (myoD1a), myocyte enhancer factor 2A (MEF2A), muscle ring finger protein 1 (MuRF1), muscle-specific X box ...
13
Stability of AML1 (core) site enhancer mutations in T lymphomas induced by attenuated SL3-3 murine leukemia virus mutants.
... transcriptional enhancer of the U3 repeat region which shows preferential activity in T ...tion factor family (also known as the core binding factor [CBF], polyomavirus enhancer binding ...
8
Identification of factor-binding sites in the duck hepatitis B virus enhancer and in vivo effects of enhancer mutations.
... Though mutations at the HNF1 site and the two HNF3 sites seemed to make the virus enhancer slightly defective in the LMH liver cell line, as expected from the assays with the hGH reporte[r] ...
11
The E47 transcription factor binds to the enhancer sequences of recombinant murine leukemia viruses and influences enhancer function.
... of enhancer activity of the two enhancers were repeated in normal cells and cells that over- expressed the E47 ...synthetic enhancer with six tandem E47- binding sites which was specifically designed to ...
7
Dilated cardiomyopathy in transgenic mice expressing a dominant negative CREB transcription factor in the heart
... transcription factor (CREBA133) under the control of the cardiac myocyte- specific alpha-MHC promoter develop dilated cardiomyopathy that closely resembles many of the anatomical, physiological, and ...
13
Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo.
... the enhancer framework, the SL3-3 enhancer diverges from both MoMLV and Akv and contains a Myb binding site and the AML1 site ...Ets factor sites can be found in other T-cell-specific enhancers, and ...
8